HCK

aview: ILA

Comprehensive solutions for early diagnosis and differentiated assessment

All products
HCK

Radiology

HCK

Interstitial Lung
Abnormalities (ILA)
Analysis Solutions



This solution specializes in evaluating lung regions for ILA, which carry the risk of evolving into interstitial lung diseases

 

Conformity Certifications

MFDS

Republic of Korea

TGA

Australia

HSA

Singapore

ANVISA

Brazil

HC

Canada

 

Analysis of interstitial lung abnormalities

The analysis meticulously assesses lung segments to identify ILA, providing distinct evaluations for fibrotic and non-fibrotic types.

HCK
 

Delivering Comprehensive Analysis Results

The system offers both quantitative and intuitive results. By dividing the lungs into six zones, it emphasizes areas where ILA distribution surpasses a 5% threshold.

HCK
 

Validations

Research confirms the effectiveness of the detection of ILA, especially when using a detection limit of 1.8% in the advanced studies.

HCK

100%

Sensitivity

HCK

99%

Specificity

HCK

0.99%

AUROC

Chae KJ, Lim S, Seo JB, Hwang HJ, Choi H, Lynch D, Jin GY. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning-based Texture Analysis. Radiology. 2023 May;307(4):e222828.

 

References:

HCK

Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning–based Texture Analysis

HCK

Interstitial lung abnormalities (ILA) on routine chest CT: Comparison of radiologists' visual evaluation and automated quantification

 
Related products
HCK

BoneAge

Automatic bone age assessment

Marked
HCK

RBhip™

Analysing Hip Dysplasia and Impingement on...

Marked
HCK

Curemetrix Suite

Triage and assistance diagnosis of breast ...

Pending